Page 41 - Pharma

Nutraplus India commissions API facility in Tarapur

The APIs manufactured in the new plant will supplied to pharmaceutical companies for producing formulations in the analgesic and other therapeutic categories

Regeneron to invest additional $ 350 mn in Irish biologics plant

With this, the total investment in Limerick site, which will be largest biopharmaceutical production facility in Ireland, will reach $ 650 million by the end of 2017

Diabetes cure: An insight into research post exit of glitazones

With increase in focus on diabetes drugs research, diabetes will be easily curable in near future as a larger number of medicine options will be available to the patients

US FDA grants approval for Aurobindo Pharma's memantine tablets

The approved product has an estimated market size of $ 1.23 billion for the twelve months ending August 2015, according to IMS

Jubilant Life Sciences receives US FDA approval for dementia drug

The company has received the ANDA approval for memantine hydrochloride tablets, a generic version of Forest Laboratories' Namenda

Arrow Coated Products receives patent for water-soluble film

The invention relates to a dosing system which contains active ingredients, embedded within and/or coated upon water soluble or water dispersible polymers

Lupin and Boehringer Ingelheim to co-market diabetes drug in India

Two companies will have signed a pact for co-marketing linagliptin, a novel dipeptidylpeptidase-4 (DPP-4) inhibitor used in the treatment of diabetes

Aijaz Tobaccowalla resigns as Pfizer India MD

S Sridhar, executive director, business unit and distribution head, appointed as temporary head till successor is appointed to Tobaccowalla

Cabinet gives nod to set up 3 new AllMS in Maharashtra, AP & WB

The government will spend Rs 4949 crore, under the Pradhan Mantri Swasthya Suraksha Yojna, to build the new All India Institutes of Medical Sciences (AllMS)

Unichem Labs receives US FDA nod for asthma drug montelukast tab

The product will be commercialised from Unichem's Goa plant

French firm Bluestar Silicones inks distribution pact with Aditya Birla Group

Grasim Industries Ltd, a flagship company of Aditya Birla Group, will become a major distributor for Bluestar's full range of silicone products in the country

Delhi HC retrains Glenmark from selling two diabetes drugs

The court has restrained Glenmark from selling two diabetes drugs - Zita and Zita-Met - as the company has infringed MSD's patent on the main ingredient, Sitagliptin

Baba Ramdev's Patanjali Ayurved joins hand with Future Group

Future Group will set up an office for storing the goods of Patanjali Ayurved in Haridwar to market and distribute ayurvedic products in modern trade through all its food-led formats

Cipla partners with Serum Institute to provide vaccines in South Africa

With this, two companies will expand their partnership, which already exists for European and Indian markets, to a new market of South Africa

Specialty chemicals industry: Making India a global manufacturing powerhouse

India can play a dominant role in the global specialty chemicals industry as it has got advantage of skilled human resources and a big consumer market

Make in India initiative can catapult India into top manufacturing economies: Pierre-Franck Valentin

In this interview, Pierre-Franck Valentin, VP & GM, Asia-Pacific, Solvay Novecare, focuses on role of specialty chemicals in making India a manufacturing hub and his growth plans for the country

Sun Pharma settles Absorica patent litigation suit with Actavis in US

As part of the settlement agreement, Actavis will start selling its generic version of Absorica in the US on December 27, 2020 (about 9 months prior to the expiration of the patents)

DBT partners with US-based Prakash Lab to procure low-cost microscope

Foldscope, a low cost paper folding-microscope developed by Dr Manu Prakash of Stanford University, will be used as an educational and training tool

Doctors Without Borders expresses discontent over Trans-Pacific Partnership pact

MSF says TPP will raise the price of medicines for millions by unnecessarily extending monopolies and further delaying price-lowering generic competition

TTK, PSG Institute, two US universities to collaborate for heart valves

Four organisations will work for the project, which is funded through a grant from National Institutes of Health (NIH) and aims to develop low cost prosthetic heart valves for India